Related Experiment Video
Updated: Jul 8, 2026
07:53
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
[A novel anticancer drug delivery system -DAC-70/CDDP]
Akio Sugitachi1, Koki Otsuka, Kentaro Fujisawa
1Dept. of Surgery, Iwate Medical University.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 29, 2008
Summary
This study developed a muco-adhesive drug delivery system using deacetylated chitin (DAC-70) for cancer treatment. The system showed enhanced muco-adhesion at body temperature and controlled drug release, suggesting clinical promise.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Oncology
Context:
- Developing effective localized cancer chemotherapy requires advanced drug delivery systems.
- Muco-adhesive materials offer potential for targeted drug release in specific tissues, like the colon.
- Chitin derivatives are explored for their biocompatibility and potential in drug encapsulation.
Purpose:
- To create and evaluate a muco-adhesive anticancer drug delivery system utilizing 70% deacetylated chitin (DAC-70).
- To assess the muco-adhesive properties and in vitro drug release profiles of cisplatin (CDDP) and 5-fluorouracil (5-FU) loaded systems.
Summary:
- A muco-adhesive system was fabricated using DAC-70 loaded with either CDDP or 5-FU.
- Ex vivo studies demonstrated increased muco-adhesion at 37°C compared to 25°C.
- In vitro release profiles showed sustained release for CDDP and burst release for 5-FU, influenced by chitin properties and drug interactions.
Impact:
- The DAC-70/CDDP system exhibits promising characteristics for loco-regional cancer chemotherapy.
- Understanding drug-chitin interactions and chitin degradability is key to optimizing release kinetics.
- This research contributes to the development of targeted and effective cancer treatment strategies.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...